Cargando…
Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425283/ https://www.ncbi.nlm.nih.gov/pubmed/37138098 http://dx.doi.org/10.1038/s41417-023-00620-3 |
_version_ | 1785089803994267648 |
---|---|
author | Yao, Jian Hui, Jian-wen Chen, Yan-jun Luo, Dong-yang Yan, Jiang-shu Zhang, Yi-fan Lan, Yuan-xiang Yan, Xiu-rui Wang, Zhi-hua Fan, Heng Xia, He-chun |
author_facet | Yao, Jian Hui, Jian-wen Chen, Yan-jun Luo, Dong-yang Yan, Jiang-shu Zhang, Yi-fan Lan, Yuan-xiang Yan, Xiu-rui Wang, Zhi-hua Fan, Heng Xia, He-chun |
author_sort | Yao, Jian |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10425283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-104252832023-08-16 Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c Yao, Jian Hui, Jian-wen Chen, Yan-jun Luo, Dong-yang Yan, Jiang-shu Zhang, Yi-fan Lan, Yuan-xiang Yan, Xiu-rui Wang, Zhi-hua Fan, Heng Xia, He-chun Cancer Gene Ther Correction Nature Publishing Group US 2023-05-03 2023 /pmc/articles/PMC10425283/ /pubmed/37138098 http://dx.doi.org/10.1038/s41417-023-00620-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Yao, Jian Hui, Jian-wen Chen, Yan-jun Luo, Dong-yang Yan, Jiang-shu Zhang, Yi-fan Lan, Yuan-xiang Yan, Xiu-rui Wang, Zhi-hua Fan, Heng Xia, He-chun Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c |
title | Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c |
title_full | Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c |
title_fullStr | Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c |
title_full_unstemmed | Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c |
title_short | Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c |
title_sort | correction to: lycium barbarum glycopeptide targets per2 to inhibit lipogenesis in glioblastoma by downregulating srebp1c |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425283/ https://www.ncbi.nlm.nih.gov/pubmed/37138098 http://dx.doi.org/10.1038/s41417-023-00620-3 |
work_keys_str_mv | AT yaojian correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c AT huijianwen correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c AT chenyanjun correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c AT luodongyang correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c AT yanjiangshu correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c AT zhangyifan correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c AT lanyuanxiang correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c AT yanxiurui correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c AT wangzhihua correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c AT fanheng correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c AT xiahechun correctiontolyciumbarbarumglycopeptidetargetsper2toinhibitlipogenesisinglioblastomabydownregulatingsrebp1c |